217 related articles for article (PubMed ID: 9385680)
1. Drug therapy in adolescents with rheumatic diseases.
Schaller JG
Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680
[No Abstract] [Full Text] [Related]
2. Medical treatment of adolescents with rheumatic disease.
Hollister JR
Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259
[TBL] [Abstract][Full Text] [Related]
3. The use of methotrexate in childhood rheumatic diseases.
Wallace CA
Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
[No Abstract] [Full Text] [Related]
4. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
Bolz M
Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
[No Abstract] [Full Text] [Related]
5. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
Falcão S; Mourão AF; Pimentão JB; Branco JC
Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198
[TBL] [Abstract][Full Text] [Related]
6. Antirheumatic drug therapy during pregnancy.
Soscia PN; Zurier RB
Bull Rheum Dis; 1997 Apr; 46(2):2-4. PubMed ID: 9104043
[No Abstract] [Full Text] [Related]
7. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
Mariette X
Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603
[No Abstract] [Full Text] [Related]
8. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
Hill J; Reay N
Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
[No Abstract] [Full Text] [Related]
9. [Individualized therapy in treatment of rheumatic diseases].
Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2449-50. PubMed ID: 17156668
[No Abstract] [Full Text] [Related]
10. [Evidence based medicine in rheumatology].
Gause A; Raspe HH
Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
[No Abstract] [Full Text] [Related]
11. [Antimalarial preparations in rheumatology: new prospects].
Nasonov EL
Ter Arkh; 1996; 68(1):67-71. PubMed ID: 8644039
[No Abstract] [Full Text] [Related]
12. Observations from the OMERACT Drug Safety Summit, May 2008.
Simon LS; Strand CV; Boers M; Brooks PM; Henry D; Tugwell PS
J Rheumatol; 2009 Sep; 36(9):2110-3. PubMed ID: 19738222
[TBL] [Abstract][Full Text] [Related]
13. Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?
Winger EE; Reed JL
J Rheumatol; 2009 Sep; 36(9):2122; author reply 2123. PubMed ID: 19738224
[No Abstract] [Full Text] [Related]
14. Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii2-ii12. PubMed ID: 15479866
[No Abstract] [Full Text] [Related]
15. [Can we treat with modern antirheumatics? Costs of NSAID treatment].
Bolten WW
Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457
[No Abstract] [Full Text] [Related]
16. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380
[No Abstract] [Full Text] [Related]
17. Pregnancy and rheumatic diseases.
Malviya AN
J Assoc Physicians India; 1994 Feb; 42(2):178. PubMed ID: 7860501
[No Abstract] [Full Text] [Related]
18. [Sulphasalazine: a promising drug in rheumatology].
Nasonov EL
Klin Med (Mosk); 1997; 75(6):39-44. PubMed ID: 9273399
[No Abstract] [Full Text] [Related]
19. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
[No Abstract] [Full Text] [Related]
20. Introduction to special section: drug safety in the rheumatic diseases.
Lovell D
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):747-8. PubMed ID: 20499388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
